Document Detail


Systemic exposure to atorvastatin between asian and caucasian subjects: a combined analysis of 22 studies.
MedLine Citation:
PMID:  20975528     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The aim of the present study was to determine whether there is a differing pattern of systemic exposure to atorvastatin in Asian versus Caucasian subjects by comparison of data obtained from completed pharmacokinetic studies. Pharmacokinetic data were analyzed from completed single-dose (10-80 mg) studies in Asian and Caucasian subjects. Dose normalized area under the concentration-time curve (AUC) and maximum observed concentration (Cmax) (AUCdn and Cmaxdn) were obtained by dividing each value by the administered dose. Dose-per-bodyweight normalized AUC and Cmax (AUCdn,wt and Cmax,dn,wt) were obtained by dividing each value by the administered dose per unit bodyweight. Mean difference and 90% confidence intervals for Asian versus Caucasian comparisons were calculated for atorvastatin pharmacokinetic values based on the t statistic and expressed as ratios using Caucasians as the reference. Data were analyzed from 310 Asians and 579 Caucasians from 22 studies. AUCdn (Asian = 2.35, Caucasian = 2.06 [ng·hr·mL]/mg) and Cmaxdn (Asian = 0.39, Caucasian = 0.40 Cmaxdn,wt) and the equivalent dose-per-bodyweight normalized values for atorvastatin (AUCdn,wt: Asian = 157.5, Caucasian = 156.4 [ng·hr·mL]/[mg·kg]; Cmaxdn,wt: Asian = 26.2, Caucasian = 30.3 [ng·mL]/[mg·kg]) were similar in both ethnic groups. Mean differences and 90% confidence interval for the differences fell within the limits (0.8-1.25) except for Cmaxdn,wt, for which the lower limit was slightly below 80%. No differences were noted in the systemic exposure to atorvastatin between Asian and Caucasian subjects. These data therefore demonstrate that dosing considerations in the current labels for atorvastatin are similar for Asian compared with Caucasian subjects.
Authors:
Kuan Gandelman; Gordon L Fung; Michael Messig; Rachel Laskey
Related Documents :
1318678 - Single-dose pharmacokinetics and antibacterial activity of daptomycin, a new lipopeptid...
6109538 - Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (sl 75212) in ma...
11360028 - Single-dose pharmacokinetics of lamotrigine in children: influence of age and antiepile...
20595378 - Interaction between topically and systemically coadministered p-glycoprotein substrates...
21345618 - Dose effect relationship for late side effects of the rectum and urinary bladder in mag...
22750998 - Foscarnet against human herpesvirus (hhv)-6 reactivation after allo-sct: breakthrough h...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of therapeutics     Volume:  19     ISSN:  1536-3686     ISO Abbreviation:  Am J Ther     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-05-08     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9441347     Medline TA:  Am J Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  164-73     Citation Subset:  IM    
Affiliation:
1Pfizer Inc, New York, NY 2UCSF Medical Center, San Francisco, CA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anatomic and functional improvements achieved by rehabilitation in Zone II and Zone V flexor tendon ...
Next Document:  A novel approach to noninferiority testing: documented proof rather than arbitrary margins.